Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy
Background The role of neck surgery in node‐positive patients whose primary tumors are treated by definitive radiotherapy is controversial. This analysis was undertaken to assess the risk of withholding planned neck dissection in patients who obtain a complete nodal response to irradiation. Methods...
Saved in:
Published in | Head & neck Vol. 18; no. 6; pp. 552 - 559 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Wiley Subscription Services, Inc., A Wiley Company
01.11.1996
John Wiley & Sons |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
The role of neck surgery in node‐positive patients whose primary tumors are treated by definitive radiotherapy is controversial. This analysis was undertaken to assess the risk of withholding planned neck dissection in patients who obtain a complete nodal response to irradiation.
Methods
We reviewed the records of 100 patients who presented between 1984 and 1993 with oropharyngeal cancers metastatic to the neck and whose primary tumors were treated by radiotherapy using the concomitant boost regimen. Seventy‐five patients had their nodal disease treated definitively by radiotherapy; those who had complete clinical resolution of all nodal disease (62) had no planned surgery, while 13 underwent neck dissection for presumed residual disease. The remaining 25 patients had either node excision (8) or neck dissection (17) prior to radiotherapy.
Results
There were 8 cases of isolated neck failure of which 3 occurred in the 62 patients who had no planned neck surgery, 0 in the 13 patients who had surgery for presumed residual (pathologically negative in 7), and 5 in the 25 patients who had initial neck surgery. In those who obtained a complete response to definitive radiotherapy, the risk of neck relapse was unrelated to pretreatment nodal size.
Conclusions
The policy of observation of the neck after complete nodal response to full‐dose irradiation is both safe and cost effective. Imaging to confirm the resolution of nodal disease is recommended. HEAD & NECK 1996;18:552–559 © 1996 John Wiley & Sons, Inc. |
---|---|
Bibliography: | ArticleID:HED10 istex:7E6303373AE3AF5D7108147128FB4FAAA7212A15 National Cancer Institute, US Dept. of Health and Human Services - No. CA06294; No. CA16672 ark:/67375/WNG-KP8MQML2-M ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1043-3074 1097-0347 |
DOI: | 10.1002/(SICI)1097-0347(199611/12)18:6<552::AID-HED10>3.0.CO;2-A |